This clinical trial, funded by the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), evaluates whether using Gentamicin Instillations can reduce the frequency of urinary tract infections (UTIs) among adults with SCI, thereby also improving their quality of life and community participation. The investigators are from both the Department of Physical Medicine (Tate, Rodriguez and Forchheimer) and the Division of Urology (Cameron) at Michigan Medicine. This trial is monitored by the Michigan Institute for Clinical and Health Research and the Food and Drug Administration (FDA). Currently several participants are enrolled in this study.
If you are interested in being part of this study in the future and have had a minimum of 2 UTIs in the last 6 months, please contact Adrienne by emailing email@example.com or calling (734) 936-9474.